Neurofeedback Group for Emotional Regulation

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Hardesty Center for Clinical Research and Neuroscience, Tulsa, OK
Emotional Regulation
Neurofeedback - Behavioral
Eligibility
Any Age
Female
What conditions do you have?
Select

Study Summary

This study will examine the effect of a real-time functional magnetic resonance imaging (fMRI) dyadic neurofeedback protocol with mothers and their adolescent daughters. Mothers in the experimental condition will view a moving bar showing their daughters' brain activity on a computer screen while talking to their daughters.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Emotional Regulation

Study Objectives

2 Primary · 5 Secondary · Reporting Duration: One year (change from first scan session to one-year follow-up)

One hour (measured during one scan session)
Blood Oxygen Level-Dependent (BOLD) signal changes (brain activation)
One year (change from first scan session to one-year follow-up)
Depressive symptoms (change over time)
Emotion regulation (change over time)
Parenting behaviors (change over time)
Resting-state network activity
Two weeks
Affect variability (change over time)
Parent-adolescent interaction quality (change over time)

Trial Safety

Safety Progress

1 of 3

Other trials for Emotional Regulation

Trial Design

2 Treatment Groups

Control Group
1 of 2
Neurofeedback Group
1 of 2
Active Control
Experimental Treatment

210 Total Participants · 2 Treatment Groups

Primary Treatment: Neurofeedback Group · No Placebo Group · N/A

Neurofeedback Group
Behavioral
Experimental Group · 1 Intervention: Neurofeedback · Intervention Types: Behavioral
Control GroupNoIntervention Group · 1 Intervention: Control Group · Intervention Types:
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Neurofeedback
2016
Completed Phase 3
~690

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: one year (change from first scan session to one-year follow-up)

Trial Background

Prof. Kara Kerr, Assistant Professor
Principal Investigator
Oklahoma State University
Closest Location: Hardesty Center for Clinical Research and Neuroscience · Tulsa, OK
N/AFirst Recorded Clinical Trial
1 TrialsResearching Emotional Regulation
0 CompletedClinical Trials

Eligibility Criteria

Age Any Age · Female Participants · 9 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.